• Akira Mitsuyoshi, Kazutaka Obama, Nobuhiko Shinkura, Takashi Ito, and Masazumi Zaima.
• Department of Surgery, Mitsubishi Kyoto Hospital, Nishikyo-ku, Kyoto 615-8087, Japan. akiram7700@yahoo.co.jp
• Ann. Surg. 2007 Aug 1;246(2):229-35.

ObjectivesThe aim of the study was to establish a procedure for early diagnosis and treatment of nonocclusive mesenteric ischemia (NOMI).BackgroundNOMI has a high mortality rate, and early diagnosis and treatment are important for improving survival in patients with this condition.MethodsThe subjects were 22 patients treated at our hospital over 13 years. Diagnostic criteria for NOMI were established based on the first 13 cases. In the 9 more recent cases, we performed abdominal contrast multidetector row computed tomography (MDCT) upon suspicion of NOMI based on these criteria. Imaging allowed definite diagnosis of NOMI, and continuous intravenous high-dose PGE1 administration was initiated immediately after diagnosis (dose, 0.01-0.03 microg/kg per min; mean administration period, 4.8 days).ResultsNine of the first 13 patients died of multiple organ failure associated with multiple intestinal necrosis. These cases suggested that NOMI may develop when 3 of the following 4 criteria are met after cardiovascular surgery or maintenance dialysis in elderly patients: symptoms of the ileus develop slowly from abdominal symptoms, such as an unpleasant abdominal feeling or pain; a requirement for catecholamine treatment; an episode of hypotension; and slow elevation of the serum transaminase level. In the 9 recent cases, definite diagnosis was made from spasm of the principal arteries in arterial volume rendering and curved planar reformation MDCT images. Early treatment with PGE1 prevented acute-stage NOMI in 8 of the 9 cases.ConclusionsEarly diagnosis of NOMI is possible using the above criteria and MDCT, and initiation of PGE1 treatment may increase survival in patients with NOMI.

30 keywords...

hide…